カンザス州における過体重の臨床試験
カンザス州内の拠点で、過体重に関する26件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Cotton O'Neil Clinical Research Center, Topeka
被験者募集中第3相
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Wichita, Wichita
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07685808A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Cotton O'Neil Clinical Research Center, Topeka
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Cotton O'Neil Clinical Research Center, Topeka
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Cotton O'Neil Diabetes & Endocrinology, Topeka
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Cotton O'Neil Diabetes & Endocrinology, Topeka
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, Newton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Lenexa
- Research Site, Newton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Wichita
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Cotton O'Neil Diabetes & Endocrinology, Topeka
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- ICON Early Phase Services, LLC, Lenexa
被験者募集中第1相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/09/04更新 · NCT07767175Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
- Alliance for Multispecialty Research LLC, Wichita
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Newton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
- University of Kansas Medical Center, Kansas City
被験者募集中
18歳〜35歳 · 全性別 · 2026/08/11更新 · NCT06961591Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Wichita
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361Gestational Response, Outcomes, and Weight After GLP-1 Use
- University of Kansas Medical Center, Kansas City
被験者募集中観察研究健康なボランティア歓迎
18歳〜45歳 · 女性 · 2026/08/04更新 · NCT07743567A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
- ICON Early Phase Services, LLC, Lenexa
被験者募集中第1相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/07/29更新 · NCT07437079Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise
- University of Kansas Medical Center, Kansas City
被験者募集中
18歳〜64歳 · 全性別 · 2026/07/15更新 · NCT07698145Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
- University of Kansas Medical Center, Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/07/02更新 · NCT06640179Muscle and Movement With Anti-Obesity Medications
- University of Kansas Medical Center, Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/05/11更新 · NCT06645470A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- Altasciences Clinical Kansas, Inc., Overland Park
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/04/21更新 · NCT07395687Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.
- University of Kansas Medical Center, Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/01/09更新 · NCT06636773ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。